Tag: Senti Biosciences
SENTI-202 by Senti Biosciences ($SNTI) Secures FDA Orphan Drug Designation for Rare Hematologic Malignancies
Senti Biosciences (SNTI) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to SENTI-202 for relapsed/refractory hematologic malignancies including AML.
SENTI-202...